vs
Side-by-side financial comparison of First Bancorp, Inc (FNLC) and Neuphoria Therapeutics Inc. (NEUP). Click either name above to swap in a different company.
First Bancorp, Inc is the larger business by last-quarter revenue ($25.8M vs $15.0M, roughly 1.7× Neuphoria Therapeutics Inc.). Neuphoria Therapeutics Inc. runs the higher net margin — 75.1% vs 39.4%, a 35.7% gap on every dollar of revenue.
Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.
Neuphoria Therapeutics Inc is a clinical-stage biopharmaceutical company focused on researching and developing innovative targeted therapies for unmet medical needs in neurological and psychiatric conditions, including anxiety, treatment-resistant depression, and other central nervous system disorders. Its core R&D efforts prioritize delivering safer, more effective treatment options for patient groups with limited existing care alternatives.
FNLC vs NEUP — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.8M | $15.0M |
| Net Profit | $10.2M | $11.3M |
| Gross Margin | — | — |
| Operating Margin | 48.1% | 79.8% |
| Net Margin | 39.4% | 75.1% |
| Revenue YoY | 17.5% | — |
| Net Profit YoY | 39.7% | — |
| EPS (diluted) | $0.91 | $6.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.8M | — | ||
| Q3 25 | $24.5M | — | ||
| Q2 25 | $22.5M | — | ||
| Q1 25 | $21.8M | $15.0M | ||
| Q4 24 | $22.0M | — | ||
| Q3 24 | $20.5M | — | ||
| Q2 24 | $19.2M | — | ||
| Q1 24 | $18.5M | — |
| Q4 25 | $10.2M | — | ||
| Q3 25 | $9.1M | — | ||
| Q2 25 | $8.1M | — | ||
| Q1 25 | $7.1M | $11.3M | ||
| Q4 24 | $7.3M | — | ||
| Q3 24 | $7.6M | — | ||
| Q2 24 | $6.2M | — | ||
| Q1 24 | $6.0M | — |
| Q4 25 | 48.1% | — | ||
| Q3 25 | 45.2% | — | ||
| Q2 25 | 43.7% | — | ||
| Q1 25 | 39.3% | 79.8% | ||
| Q4 24 | 39.5% | — | ||
| Q3 24 | 44.6% | — | ||
| Q2 24 | 38.8% | — | ||
| Q1 24 | 39.3% | — |
| Q4 25 | 39.4% | — | ||
| Q3 25 | 37.0% | — | ||
| Q2 25 | 35.8% | — | ||
| Q1 25 | 32.5% | 75.1% | ||
| Q4 24 | 33.1% | — | ||
| Q3 24 | 36.9% | — | ||
| Q2 24 | 32.1% | — | ||
| Q1 24 | 32.5% | — |
| Q4 25 | $0.91 | — | ||
| Q3 25 | $0.81 | — | ||
| Q2 25 | $0.72 | — | ||
| Q1 25 | $0.63 | $6.55 | ||
| Q4 24 | $0.66 | — | ||
| Q3 24 | $0.68 | — | ||
| Q2 24 | $0.55 | — | ||
| Q1 24 | $0.54 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $17.0M |
| Total DebtLower is stronger | $95.5M | — |
| Stockholders' EquityBook value | $283.1M | $26.0M |
| Total Assets | $3.2B | $30.7M |
| Debt / EquityLower = less leverage | 0.34× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $17.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $95.5M | — | ||
| Q3 25 | $95.5M | — | ||
| Q2 25 | $95.0M | — | ||
| Q1 25 | $70.0M | — | ||
| Q4 24 | $95.0M | — | ||
| Q3 24 | $95.0M | — | ||
| Q2 24 | $70.0M | — | ||
| Q1 24 | $70.0M | — |
| Q4 25 | $283.1M | — | ||
| Q3 25 | $274.6M | — | ||
| Q2 25 | $265.5M | — | ||
| Q1 25 | $259.7M | $26.0M | ||
| Q4 24 | $252.5M | — | ||
| Q3 24 | $256.8M | — | ||
| Q2 24 | $244.7M | — | ||
| Q1 24 | $242.6M | — |
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.2B | — | ||
| Q2 25 | $3.2B | — | ||
| Q1 25 | $3.2B | $30.7M | ||
| Q4 24 | $3.2B | — | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $3.1B | — | ||
| Q1 24 | $3.0B | — |
| Q4 25 | 0.34× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.36× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.38× | — | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.29× | — | ||
| Q1 24 | 0.29× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $37.8M | $11.5M |
| Free Cash FlowOCF − Capex | $34.6M | — |
| FCF MarginFCF / Revenue | 133.9% | — |
| Capex IntensityCapex / Revenue | 12.5% | — |
| Cash ConversionOCF / Net Profit | 3.72× | 1.02× |
| TTM Free Cash FlowTrailing 4 quarters | $55.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.8M | — | ||
| Q3 25 | $12.9M | — | ||
| Q2 25 | $7.4M | — | ||
| Q1 25 | $2.2M | $11.5M | ||
| Q4 24 | $26.0M | — | ||
| Q3 24 | $9.8M | — | ||
| Q2 24 | $6.4M | — | ||
| Q1 24 | $-1.5M | — |
| Q4 25 | $34.6M | — | ||
| Q3 25 | $12.6M | — | ||
| Q2 25 | $7.2M | — | ||
| Q1 25 | $828.0K | — | ||
| Q4 24 | $24.6M | — | ||
| Q3 24 | $9.6M | — | ||
| Q2 24 | $6.3M | — | ||
| Q1 24 | $-1.8M | — |
| Q4 25 | 133.9% | — | ||
| Q3 25 | 51.4% | — | ||
| Q2 25 | 32.1% | — | ||
| Q1 25 | 3.8% | — | ||
| Q4 24 | 111.7% | — | ||
| Q3 24 | 47.0% | — | ||
| Q2 24 | 32.9% | — | ||
| Q1 24 | -9.8% | — |
| Q4 25 | 12.5% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 6.2% | — | ||
| Q4 24 | 6.7% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 1.8% | — |
| Q4 25 | 3.72× | — | ||
| Q3 25 | 1.42× | — | ||
| Q2 25 | 0.91× | — | ||
| Q1 25 | 0.31× | 1.02× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 1.29× | — | ||
| Q2 24 | 1.03× | — | ||
| Q1 24 | -0.25× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
